CASTLE BIOSCIENCES, INC. Increase (Decrease) in Accounts Receivable
CASTLE BIOSCIENCES, INC. (CSTL) reported Increase (Decrease) in Accounts Receivable of $4.74 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $5.82M.
- CASTLE BIOSCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$1.07M, a 120.61% decline year-over-year.
- CASTLE BIOSCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$6.27M, a 915.60% decline year-over-year.
- CASTLE BIOSCIENCES, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$1.91M, a 144.92% decline year-over-year.
- CASTLE BIOSCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2025 was -$6.88M, a 154.39% decline from fiscal 2024.
- CASTLE BIOSCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2024 was $12.64M, a 15.32% decline from fiscal 2023.
- CASTLE BIOSCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2023 was $14.93M, a 140.11% increase from fiscal 2022.
- CASTLE BIOSCIENCES, INC. increase (decrease) in accounts receivable for fiscal 2022 was $6.22M, a 34.27% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $4.74M 10-Q · filed 2026-07-30 | -$1.53M derived: sum of 3 quarters · filed 2026-07-30 | -$3.44M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2026-03-31 | -$1.07M 10-Q · filed 2026-05-06 | -$7.35M derived: sum of 2 quarters · filed 2026-05-06 | -$9.26M derived: sum of 3 quarters · filed 2026-05-06 | -$13.17M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-12-31 | -$6.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$8.18M derived: sum of 2 quarters · filed 2026-02-26 | -$12.09M derived: sum of 3 quarters · filed 2026-07-30 | -$6.88M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | -$1.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$5.82M derived: sum of 2 quarters · filed 2026-07-30 | -$604.00K 10-Q · filed 2025-11-03 | $165.00K derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-06-30 | -$3.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $1.31M 10-Q · filed 2026-07-30 | $2.08M derived: sum of 3 quarters · filed 2026-07-30 | $6.33M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-03-31 | $5.22M 10-Q · filed 2026-05-06 | $5.99M derived: sum of 2 quarters · filed 2026-05-06 | $10.24M derived: sum of 3 quarters · filed 2026-05-06 | $13.60M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | $769.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.02M derived: sum of 2 quarters · filed 2026-02-26 | $8.38M derived: sum of 3 quarters · filed 2026-02-26 | $12.64M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $4.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $7.61M derived: sum of 2 quarters · filed 2025-11-03 | $11.87M 10-Q · filed 2025-11-03 | $13.03M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $3.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $7.62M 10-Q · filed 2025-08-04 | $8.77M derived: sum of 3 quarters · filed 2026-02-26 | $14.57M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $4.26M 10-Q · filed 2025-05-05 | $5.41M derived: sum of 2 quarters · filed 2026-02-26 | $11.21M derived: sum of 3 quarters · filed 2026-02-26 | $14.81M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.95M derived: sum of 2 quarters · filed 2026-02-26 | $10.55M derived: sum of 3 quarters · filed 2026-02-26 | $14.93M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $5.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $9.40M derived: sum of 2 quarters · filed 2024-11-04 | $13.78M 10-Q · filed 2024-11-04 | $14.32M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $3.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $7.98M 10-Q · filed 2024-08-05 | $8.52M derived: sum of 3 quarters · filed 2025-02-27 | $8.57M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $4.38M 10-Q · filed 2024-05-02 | $4.92M derived: sum of 2 quarters · filed 2025-02-27 | $4.97M derived: sum of 3 quarters · filed 2025-02-27 | $7.88M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $540.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $590.00K derived: sum of 2 quarters · filed 2025-02-27 | $3.49M derived: sum of 3 quarters · filed 2025-02-27 | $6.22M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $2.95M derived: sum of 2 quarters · filed 2023-11-02 | $5.68M 10-Q · filed 2023-11-02 | $4.22M derived: sum of 4 quarters · filed 2023-11-02 | ||
| 2022-06-30 | $2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $5.63M 10-Q · filed 2023-08-02 | $4.17M derived: sum of 3 quarters · filed 2023-08-02 | $4.98M derived: sum of 4 quarters · filed 2023-08-02 | ||
| 2022-03-31 | $2.73M 10-Q · filed 2023-05-03 | $1.27M derived: sum of 2 quarters · filed 2023-05-03 | $2.08M derived: sum of 3 quarters · filed 2023-05-03 | $5.80M derived: sum of 4 quarters · filed 2023-05-03 | ||
| 2021-12-31 | -$1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$644.00K derived: sum of 2 quarters · filed 2023-02-28 | $3.07M derived: sum of 3 quarters · filed 2023-02-28 | $4.63M 10-K · filed 2023-02-28 | ||
| 2021-09-30 | $812.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $4.53M derived: sum of 2 quarters · filed 2022-11-02 | $6.09M 10-Q · filed 2022-11-02 | $6.28M derived: sum of 4 quarters · filed 2022-11-02 | ||
| 2021-06-30 | $3.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $5.28M 10-Q · filed 2022-08-08 | $5.47M derived: sum of 3 quarters · filed 2022-08-08 | $5.95M derived: sum of 4 quarters · filed 2022-08-08 | ||
| 2021-03-31 | $1.56M 10-Q · filed 2022-05-09 | $1.75M derived: sum of 2 quarters · filed 2022-05-09 | $2.23M derived: sum of 3 quarters · filed 2022-05-09 | $56.00K derived: sum of 4 quarters · filed 2022-05-09 | ||
| 2020-12-31 | $192.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $674.00K derived: sum of 2 quarters · filed 2022-02-28 | -$1.50M derived: sum of 3 quarters · filed 2022-02-28 | -$1.66M 10-K · filed 2022-02-28 | ||
| 2020-09-30 | $482.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$1.69M derived: sum of 2 quarters · filed 2021-11-08 | -$1.85M 10-Q · filed 2021-11-08 | -$158.00K derived: sum of 4 quarters · filed 2021-11-08 | ||
| 2020-06-30 | -$2.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$2.34M 10-Q · filed 2021-08-09 | -$640.00K derived: sum of 3 quarters · filed 2021-08-09 | $2.18M derived: sum of 4 quarters · filed 2021-08-09 | ||
| 2020-03-31 | -$161.00K 10-Q · filed 2021-05-10 | $1.54M derived: sum of 2 quarters · filed 2021-05-10 | $4.36M derived: sum of 3 quarters · filed 2021-05-10 | $4.58M derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2019-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $4.52M derived: sum of 2 quarters · filed 2021-03-11 | $4.74M derived: sum of 3 quarters · filed 2021-03-11 | $896.00K 10-K · filed 2021-03-11 | ||
| 2019-09-30 | $2.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $3.04M derived: sum of 2 quarters · filed 2020-11-09 | -$801.00K 10-Q · filed 2020-11-09 | -$800.60K 10-Q · filed 2019-11-12 | $6.95M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $216.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$3.63M 10-Q · filed 2020-08-10 | -$3.63M 10-Q · filed 2019-09-03 | $4.13M derived: sum of 3 quarters · filed 2020-08-10 | $4.16M derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | -$3.84M 10-Q · filed 2020-05-11 | $3.91M derived: sum of 2 quarters · filed 2020-05-11 | $3.95M derived: sum of 3 quarters · filed 2020-05-11 | |||
| 2018-12-31 | $7.75M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $7.79M derived: sum of 2 quarters · filed 2020-03-10 | $8.41M 10-K · filed 2020-03-10 | |||
| 2018-09-30 | $34.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $655.25K 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | $621.17K 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |